Concept

Enoxaparin sodium

OpenAlex ID: C2778825682

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

2008 · Bengt I. Eriksson, Lars C. Borris, et al. · New England Journal of Medicine · 1,430

PDF

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

2008 · Michael R. Lassen, Walter Ageno, et al. · New England Journal of Medicine · 1,297

PDF

Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes

2006 · The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators · New England Journal of Medicine · 1,230

PDF

Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial

2008 · Ajay K Kakkar, Benjamin Brenner, et al. · The Lancet · 1,073

Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 · Elliott M. Antman, Carolyn H. McCabe, et al. · Circulation · 1,040

PDF

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

2002 · Guy Meyer, Zora Marjanovic, et al. · Archives of Internal Medicine · 796

Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

2010 · Michael Rud Lassen, Alexander Gallus, et al. · New England Journal of Medicine · 779

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

2010 · Michael Rud Lassen, Gary E Raskob, et al. · The Lancet · 775

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

2012 · Erica Villa, Calogero Cammà, et al. · Gastroenterology · 746

Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery A Meta-analysis of 4 Randomized Double-blind Studies

2002 · Alexander G. G. Turpie · Archives of Internal Medicine · 725

Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

2008 · Jeffrey S Ginsberg, Bruce L Davidson, et al. · The Journal of Arthroplasty · 631

Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

2004 · Harry R. Büller, Bruce L. Davidson, et al. · Annals of Internal Medicine · 608

Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 · Elliott M. Antman, Marc Cohen, et al. · Circulation · 469

PDF

Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement

1996 · David Bergqvist, Göran Benoni, et al. · New England Journal of Medicine · 447

PDF

Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis

1982 · Russell Hull, Terry Delmore, et al. · New England Journal of Medicine · 435

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

1996 · André Planes, Nicole Vochelle, et al. · The Lancet · 417

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

2006 · Steven R. Deitcher, Craig M. Kessler, et al. · Clinical and Applied Thrombosis/Hemostasis · 396

Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease

2001 · Geno Merli, Theodore E. Spiro, et al. · Annals of Internal Medicine · 361

Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention

2006 · Gilles Montalescot, Harvey D. White, et al. · New England Journal of Medicine · 357

PDF

A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement

2006 · Bengt I. Eriksson, Lars C. Borris, et al. · Circulation · 333

Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes

2004 · John L. Petersen, Kenneth W. Mahaffey, et al. · JAMA · 331

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

2007 · David G Sherman, Gregory W Albers, et al. · The Lancet · 325

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

2011 · Gilles Montalescot, Uwe Zeymer, et al. · The Lancet · 320

Comparison of Enoxaparin and Warfarin for the Prevention of Venous Thromboembolic Disease After Total Hip Arthroplasty. Evaluation During Hospitalization and Three Months After Discharge*

1999 · CLIFFORD W. COLWELL, DENNIS K. COLLIS, et al. · Journal of Bone and Joint Surgery · 295

Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

2007 · Shamir R. Mehta, Christopher B. Granger, et al. · Journal of the American College of Cardiology · 264

PDF

Works count: 1,641

Citation count: 39,170